Furthermore, recent research has revealed lower expression levels of MCF2L and other genes involved in Rho signal transduction in stage 4 NB patients with unfavorable prognosis compared to those with the same disease stage but a more favorable outcome [44]. Here, RHO is linked to neuroblastoma.